Daxdilimab (VIB7734) is a fully human monoclonal antibody targeting ILT7 (LILRA4), which is specifically expressed on plasmacytoid dendritic cells (pDCs). Daxdilimab depletes pDCs in circulation and tissues by inducing ADCC. As pDCs are the primary source of Type 1 interferons (IFN-I), this antibody effectively reduces IFN-I production and suppresses interferon-inducible gene signatures, serving as a tool for researching autoimmune diseases like SLE, dermatomyositis, and Sjögrens syndrome.
CAS Nummer:
[2245966-28-1]
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
